| 1 |
35126884 | Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing. | 2022 |
2 |
| 2 |
31257011 | Montelukast, Leukotriene Inhibitor, Reduces LPS-Induced Acute Lung Inflammation and Human Neutrophil Activation. | 2019 Nov |
1 |
| 3 |
31313075 | Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrier. | 2019 Oct |
2 |
| 4 |
29890415 | Montelukast inhibits inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes. | 2018 Aug |
1 |
| 5 |
24080250 | Inhibitory effects of Montelukast on mediator release by nasal epithelial cells from asthmatic subjects with or without allergic rhinitis. | 2013 Dec |
1 |
| 6 |
21122279 | Montelukast reduces eosinophilic inflammation by inhibiting both epithelial cell cytokine secretion (GM-CSF, IL-6, IL-8) and eosinophil survival. | 2010 Oct-Dec |
1 |
| 7 |
15984600 | Effect of montelukast on nuclear factor kappaB activation and proinflammatory molecules. | 2005 Jun |
2 |